NanoEcho wins tender and moves closer to its first revenues

2025-08-18

On Thursday, 14 August, the fantastic news was announced that NanoEcho has won a public tender and has been appointed as the supplier of a research system to Lund University. The tender is a very important step towards generating the first revenues and forms part of the long-term strategy to gradually build up delivery and support capacity ahead of the future commercial launch.

Read the full press release here! (in Swedish)

Read the investor letter, where CEO Linda Persson and CTO Magnus Santesson share their reflections on the tender and how it strengthens NanoEcho’s position going forward. (in Swedish)

Watch CEO Linda Persson briefly comment on the news in the video below! (subtitled in English)

NanoEcho’s innovative method, with its high precision, aims to facilitate the differentiation between diseased and healthy tissue and at the same time determine a more precise localization of cancerous tissue. The goal is to provide a more reliable diagnosis of, for example cancer diseases, that has the potential to contribute to cost-effectiveness in the health care.

Not For Sale – For Clinical Investigation Use Only – EU Trial No.: 2024-515335-29-00

NanoEcho AB
Scheelevägen 19,
223 63 Lund
info@nanoecho.se